
Biocon
company0.0Global Dominance: 0.00%
Biocon is a leading biopharmaceutical company in India, renowned for its pioneering approach to biotechnology and its commitment to developing affordable healthcare solutions. The company was highlighted in the news following the announcement of the 'Biopharma Shakti' program in Budget 2026, aimed at enhancing local production of biologics and biosimilars, positioning Biocon favorably for future growth in the biopharmaceutical sector.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Biocon is positioned favorably as a frontrunner in the local production of biologics and biosimilars.
Budget 2026 impact on stock market: Which are the top stocks in focus? Check listThe Times of India·
India· 2026-02-01

